Paratek Pharmaceuticals
PRTK
#9532
Rank
A$0.18 B
Marketcap
A$3.25
Share price
0.00%
Change (1 day)
9.47%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -A$66.28 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are A$0.16 Billion. In 2022 the company made an earning of -A$66.14 Million a decrease over its 2021 earnings that were of -A$59.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$66.28 Million0.21%
2022 -A$66.14 Million10.5%
2021 -A$59.86 Million-46.16%
2020 -A$0.12 Billion-31.93%
2019 -A$0.17 Billion11.12%
2018 -A$0.15 Billion21.19%
2017 -A$0.13 Billion-23.22%
2016 -A$0.16 Billion54.68%
2015 -A$0.11 Billion309.5%
2014 -A$24.94 Million-29.88%
2013 -A$35.57 Million
2011 -A$5.49 Million-59.18%
2010 -A$13.44 Million-53.53%
2009 -A$28.92 Million-161.93%
2008 A$46.69 M-187.43%
2007 -A$53.41 Million11.93%
2006 -A$47.72 Million31.69%
2005 -A$36.23 Million32.4%
2004 -A$27.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-A$0.74 Billion 1,056.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$90.17 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.22 B-445.57%๐Ÿ‡บ๐Ÿ‡ธ USA